Search research articles
Contact Us
Filters
Showing results (11-20 of 79) with videos related to
Page
of 8
Sort By:
Journal of Proteomics
|
July 22, 2023
Unbiased differential proteomic profiling between cancer-associated fibroblasts and cancer cell lines
Rachel Lau, Lu Yu, Theodoros I Roumeliotis, et al.
Journal of Proteomics
|
September 7, 2024
Corrigendum to "Unbiased differential proteomic profiling between cancer-associated fibroblasts and cancer cell lines" [Journal of Proteomics (2023) Volume 288, Article number 104973]
Rachel Lau, Lu Yu, Theodoros I Roumeliotis, et al.
Nature Reviews. Cancer
|
June 18, 2020
Prostate carcinogenesis: inflammatory storms
Johann S de Bono, Christina Guo, Bora Gurel, et al.
Cancer
|
June 8, 2012
An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy
Emmanuel S Antonarakis, Daniel Keizman, Zhe Zhang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 16, 2016
PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillance
Bruce J Trock, Helen Fedor, Bora Gurel, et al.
The American Journal of Surgical Pathology
|
July 1, 2010
NKX3.1 as a marker of prostatic origin in metastatic tumors
Bora Gurel, Tehmina Z Ali, Elizabeth A Montgomery, et al.
Lung Cancer Management
|
June 4, 2021
HER3 expression and MEK activation in non-small-cell lung carcinoma
Thubeena Manickavasagar, Wei Yuan, Suzanne Carreira, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
May 1, 2015
Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial
Sarah H Nash, Jeannette M Schenk, Alan R Kristal, et al.
European Urology
|
January 7, 2023
A Transgender Patient with Prostate Cancer: Lessons Learnt
Khobe Chandran, Rafael Grochot, Maria de Los Dolores Fenor De La Maza, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 24, 2008
Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis
Bora Gurel, Tsuyoshi Iwata, Cheryl M Koh, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 79) with videos related to
Sort By:
Page
of 8
Journal of Proteomics
|
July 22, 2023
Unbiased differential proteomic profiling between cancer-associated fibroblasts and cancer cell lines
Rachel Lau, Lu Yu, Theodoros I Roumeliotis, et al.
Journal of Proteomics
|
September 7, 2024
Corrigendum to "Unbiased differential proteomic profiling between cancer-associated fibroblasts and cancer cell lines" [Journal of Proteomics (2023) Volume 288, Article number 104973]
Rachel Lau, Lu Yu, Theodoros I Roumeliotis, et al.
Nature Reviews. Cancer
|
June 18, 2020
Prostate carcinogenesis: inflammatory storms
Johann S de Bono, Christina Guo, Bora Gurel, et al.
Cancer
|
June 8, 2012
An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy
Emmanuel S Antonarakis, Daniel Keizman, Zhe Zhang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 16, 2016
PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillance
Bruce J Trock, Helen Fedor, Bora Gurel, et al.
The American Journal of Surgical Pathology
|
July 1, 2010
NKX3.1 as a marker of prostatic origin in metastatic tumors
Bora Gurel, Tehmina Z Ali, Elizabeth A Montgomery, et al.
Lung Cancer Management
|
June 4, 2021
HER3 expression and MEK activation in non-small-cell lung carcinoma
Thubeena Manickavasagar, Wei Yuan, Suzanne Carreira, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
May 1, 2015
Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial
Sarah H Nash, Jeannette M Schenk, Alan R Kristal, et al.
European Urology
|
January 7, 2023
A Transgender Patient with Prostate Cancer: Lessons Learnt
Khobe Chandran, Rafael Grochot, Maria de Los Dolores Fenor De La Maza, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 24, 2008
Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis
Bora Gurel, Tsuyoshi Iwata, Cheryl M Koh, et al.
Page
of 8